6.26 USD
▼-0.78-11.02%
盘后 0.42 0.00%
2026-09-16
市值
$12.00M
市盈率
—
EPS
-8.73
股息率
—
52 周区间
5.00 – 26.64
成交量
22.53K
Beta
1.58
目标价
6.88
52W 低 5.0052W 高 26.64
价格走势
公司简介
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company’s lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer’s, as well as under preclinical stu...